Neurocrine Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $993.2M
Liabilities Breakdown FY2018
Total Liabilities: $512.4M
Asset Breakdown
Total Assets: $993.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $141.7M | 14.3% |
| Accounts Receivable | $57.4M | 5.8% |
| Inventory | $10.9M | 1.1% |
| Property, Plant & Equipment | $33.9M | 3.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $749.3M | 75.4% |
Liabilities Breakdown
Total Liabilities: $512.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $13.8M | 2.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $498.6M | 97.3% |